G207 virus plus radiation for children with aggressive brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether combining G207 (a specially modified virus) with radiation therapy can help treat high-grade gliomas—aggressive brain tumors in children. G207 is designed to attack cancer cells while sparing healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child or young adult with a high-grade glioma (aggressive brain tumor)
- Your tumor cannot be in the cerebellum, brainstem, or spinal cord
- You cannot have cancer that has spread to multiple lobes of the brain or to other parts of your body
- You cannot be pregnant or breastfeeding (females must use birth control during the trial)
- You cannot be taking high doses of steroids (like dexamethasone) or antiviral drugs that fight herpes
- You must be willing and able to return for follow-up visits and scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination treatment for children and young adults with brain tumors that have come back or not responded to standard therapy. The treatment includes a gene therapy (SGT-53) that delivers a normal TP53 gene, a checkpoint inhibitor drug that helps the immune system attack the cancer, and focused radiation. The goal is to see if this combination is safe and can shrink tumors.
This trial tests a new gene therapy given directly into the brain tumor. It's for people with high-grade glioma, either newly diagnosed or after one recurrence, to see if it can help control the tumor.
This trial tests a modified herpes virus (M032) given directly into the brain tumor after standard radiation. The goal is to see if this virus can slow or stop the growth of diffuse midline glioma, a type of brain cancer.
This trial studies a gene-based treatment (HSV-tk) given with radiation and chemotherapy for people newly diagnosed with glioblastoma or anaplastic astrocytoma. It may help the new brain tumor respond better to standard treatments, though risks and benefits are still being tested.
This trial is testing a virus called HSV G207, which is injected directly into the tumor, to treat children and young adults with a type of brain tumor in the cerebellum that has come back or not responded to standard treatments.
This trial tests adding atovaquone to standard radiation therapy for children with aggressive brain tumors like high-grade glioma (a fast-growing brain cancer) or medulloblastoma. The goal is to see if this drug, which targets energy production in cancer cells, can make radiation work better.
Hear when a new High Grade Gliomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.